Discrimination and Tobacco Use in LGBTQ Young Adults

Apr.20.2023
Discrimination and Tobacco Use in LGBTQ Young Adults
Tobacco Control is an international journal that studies the effects of tobacco on health, economy, environment, and society.

Tobacco Control is an international journal aimed at studying the nature and consequences of tobacco use worldwide, including its impact on population health, the economy, the environment, and society. The journal seeks to prevent and control the widespread use of tobacco through promoting public knowledge of tobacco, industry ethics, policy-making, and social activism by the tobacco industry and its allies, playing a positive role in these areas. On December 7, 2022, the journal published a paper entitled "Discrimination, Identity Connectedness and Tobacco Use in a Sample of Sexual and Gender Minority Young Adults".


Source of image: The front page of the December 2022 issue of "Tobacco Control" journal, featuring an article on discrimination, identity affiliation, and smoking behavior among young adults in the LGBTQ community.


The summary of this paper can be translated into standard journalistic English as follows:


Title: Higher Tobacco Use Among Sexual and Gender Minority Populations According to previous research in academia, a widely accepted viewpoint is that sexual and gender minority (SGM) populations have higher smoking rates than heterosexual or cisgender populations. However, there is little research exploring the smoking habits of different racial/ethnic SGM subgroups or the association between SGM-specific discrimination and identity with smoking behavior. A new study in the United States has shown that SGM populations have higher tobacco use rates compared to heterosexual populations. The study also found differences in tobacco use rates among SGM subgroups based on ethnicity and identity.


The research team includes experts and scholars Alex Budenz, Jennifer Gaber, Erik Crankshaw, Andie Malterud, Emily B Peterson, Dana E Wagner, and Emily C Sanders. These individuals come from various organizations, including the Center for Tobacco Products in the Office of Health Communication and Education at the U.S. Food and Drug Administration, the Center for Health Analytics, Media and Policy at RTI International, and the Research Department at Rescue Agency.


Research methodology: This study surveyed 11,313 young American sexual and gender minority (SGM) adults to investigate the associations between different tobacco use methods (including traditional cigarettes, e-cigarettes, cigars, and tobacco powder) and SGM sub-populations, race/ethnicity, SGM-specific discrimination, and identity. Data analysis was conducted using multiple logistic regression models to predict the relationships between SGM sub-populations, race/ethnicity, SGM-specific discrimination, identity, and various tobacco use methods.


Investigation Results: The study revealed that there are differences in tobacco use among sub-groups of the sexual minority population and between different races/ethnicities. Female homosexuals (especially black female homosexuals) are more likely than average to use multiple tobacco products. White bisexuals and female homosexuals have a higher likelihood of smoking cigarettes and e-cigarettes than the average. Severe discrimination is associated with the use of multiple tobacco products, and the more likely SGM groups are to identify with discrimination and tobacco use being positively correlated, the more likely they are to defend their smoking behavior as being reasonable.


Conclusion: This study found differences in tobacco use among SGM subgroups and among different races/ethnicities. Experiencing discrimination may be a risk factor for tobacco use behavior, while a strong sense of SGM identity may provide an explanatory role for certain tobacco use behaviors among gender and sexual minorities and those experiencing specific SGM discrimination. These findings can guide targeted approaches to reach SGM subgroups at higher risk for tobacco use. The researchers call for the development of more comprehensive and precise policies and interventions to eliminate the inequality surrounding this public health issue.


Reference:


Discrimination, Identity Connections, and Tobacco Use Among Sexual and Gender Minority Young Adults: A Study


Related Reading:


【Science】Latest scientific research clarifies the link between nicotine addiction and human identity cognition.


A recent scientific experiment shows that the flavor of nicotine and marijuana-based electronic cigarette products is a factor in attracting more adolescents to try them.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
PMI CEO Attends Opening of IQOS Global Flagship in Tokyo’s Ginza as 1,814 Limited ILUMA i PRIME Sets Launch
IQOS opened its first global flagship, IQOS Flagship Ginza, in Tokyo on September 4, 2026, replacing the former IQOS Store Ginza after nearly a decade of operation. The new location expands conventional product retail into member lounges, digital experiences, art installations and brand programming. IQOS also launched a Ginza-exclusive IQOS ILUMA i PRIME set limited to 1,814 individually numbered units, priced at JPY11,980, or about US$77. PMI Sales Strategy Consultant Yuji M. later said on LinkedIn that more than 500 people had lined up from the night before the opening.
Sep.07
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Product | Philip Morris Launches TEREA Bold Red and Bold Black in Germany With Level-10 Tobacco Intensity at €8 per Pack
Philip Morris International (PMI) introduced TEREA Bold Red and Bold Black heated tobacco sticks in Germany in October 2026, both carrying a brand-rated tobacco-flavor intensity of 10, the highest level in the country's TEREA portfolio. Bold Red features leather and warm woody notes, while Bold Black combines woody and subtle floral notes. Both are sold in 20-stick packs at €8, approximately 2.6% above standard TEREA products. Germany's TEREA range now includes 11 flavor variants, alongside a separate 26-stick XL format priced at €10. IQOS Germany announced the new products on October 12, followed by a phased retail rollout from late October and an IQOS Club campaign running through December.
product
Nov.02
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23